GlassScriptPhysician profile
Kathryn L Keys
NPI 1962732727
$1,829.90
in general payments reported to CMS, 2019-2025
10 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $493 · 2023: $419 · 2024: $156 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $777.21 | 2021-2025 | Xeomin |
| W. L. Gore & Associates, INC. | $183.41 | 2022-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Stryker Corporation | $158.09 | 2025 | Flowtriever |
| Livanova USA, INC. | $156.25 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Inari Medical, INC. | $131.43 | 2021 | |
| Endologix LLC | $126.75 | 2023 | |
| Angiodynamics, INC. | $121.34 | 2021 | |
| Cardiovascular Systems INC. | $117.97 | 2021 | |
| Terumo Medical Corporation | $35.76 | 2022 | |
| Galderma Laboratories, L.P. | $21.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Keys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.